Long-term survival analysis of free flap reconstruction in patients with collagen vascular disorders.
Abstract
[BACKGROUND] Collagen vascular disorders (CVD) are inflammatory diseases that can affect the blood vessels and soft tissues. Patients with CVD are often immunosuppressed, prone to hyper-coagulation, and represent a challenging patient cohort for free tissue transfer.
[METHODS] A retrospective review of patients with CVD who underwent free flap reconstructions from 2000-2020 was performed at our institution. Inclusion criteria were patients 18 years old or older with the clinical diagnosis of CVD, including rheumatoid arthritis, Raynaud phenomenon, systemic lupus erythematosus, scleroderma, and sarcoidosis. A time-to-event analysis was performed to identify predictors of surgical complications.
[RESULTS] A total of 78 patients and 96 free flaps were included. The most common CVD were rheumatoid arthritis (n=36) and Raynaud's phenomenon (n=9). Type of flap included abdominal-based flap (26%), trunk-based flaps (32.3%), and extremity-based flaps (19.8%). The mean age was 56.7±14.6 years, and the mean BMI was 27.5±5.9 kg/m2. Antibody positivity was present in 25.6% of patients; 59% were on chronic steroids, 6.4% were on chronic anticoagulation, 35.9% had radiation therapy, and 29.5% had chemotherapy. Nine percent of patients had a history of prior flap loss, and 11.5% had a history of DVT or arterial thrombosis. The flap loss rate was 3.8%. Steroid treatment was associated with an increased risk of major complications after adjusting for the type of flap HR 2.5(1.3-4.9), p= 0.01. Specifically associated with a higher risk of cellulitis, OR 5.1 (1.1-24.5), p=0.02, and abscess, OR 5.7 (1.2-27.1), p=0.01.
[CONCLUSION] Free flap reconstruction can be safely performed in patients with CVD. Perioperative optimization of steroids is important to promote wound healing and stabilize disease activity.
[METHODS] A retrospective review of patients with CVD who underwent free flap reconstructions from 2000-2020 was performed at our institution. Inclusion criteria were patients 18 years old or older with the clinical diagnosis of CVD, including rheumatoid arthritis, Raynaud phenomenon, systemic lupus erythematosus, scleroderma, and sarcoidosis. A time-to-event analysis was performed to identify predictors of surgical complications.
[RESULTS] A total of 78 patients and 96 free flaps were included. The most common CVD were rheumatoid arthritis (n=36) and Raynaud's phenomenon (n=9). Type of flap included abdominal-based flap (26%), trunk-based flaps (32.3%), and extremity-based flaps (19.8%). The mean age was 56.7±14.6 years, and the mean BMI was 27.5±5.9 kg/m2. Antibody positivity was present in 25.6% of patients; 59% were on chronic steroids, 6.4% were on chronic anticoagulation, 35.9% had radiation therapy, and 29.5% had chemotherapy. Nine percent of patients had a history of prior flap loss, and 11.5% had a history of DVT or arterial thrombosis. The flap loss rate was 3.8%. Steroid treatment was associated with an increased risk of major complications after adjusting for the type of flap HR 2.5(1.3-4.9), p= 0.01. Specifically associated with a higher risk of cellulitis, OR 5.1 (1.1-24.5), p=0.02, and abscess, OR 5.7 (1.2-27.1), p=0.01.
[CONCLUSION] Free flap reconstruction can be safely performed in patients with CVD. Perioperative optimization of steroids is important to promote wound healing and stabilize disease activity.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | flap
|
피판재건술 | dict | 5 | |
| 시술 | free flap
|
피판재건술 | dict | 3 | |
| 해부 | soft tissues
|
scispacy | 1 | ||
| 해부 | tissue
|
scispacy | 1 | ||
| 해부 | flaps
|
scispacy | 1 | ||
| 합병증 | cellulitis
|
감염 | dict | 1 | |
| 합병증 | abdominal-based flap
|
scispacy | 1 | ||
| 합병증 | extremity-based flaps
|
scispacy | 1 | ||
| 합병증 | flap HR
|
scispacy | 1 | ||
| 합병증 | wound
|
scispacy | 1 | ||
| 약물 | steroids
|
C0038317
Steroids
|
scispacy | 1 | |
| 약물 | Steroid
|
C0038317
Steroids
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Collagen vascular
|
scispacy | 1 | ||
| 약물 | [RESULTS] A
|
scispacy | 1 | ||
| 약물 | p=0.02
|
scispacy | 1 | ||
| 질환 | collagen vascular disorders
|
scispacy | 1 | ||
| 질환 | vascular disorders
|
C0042373
Vascular Diseases
|
scispacy | 1 | |
| 질환 | CVD
→ Collagen vascular disorders
|
scispacy | 1 | ||
| 질환 | rheumatoid arthritis
|
C0003873
Rheumatoid Arthritis
|
scispacy | 1 | |
| 질환 | Raynaud phenomenon
|
C0034735
Raynaud Phenomenon
|
scispacy | 1 | |
| 질환 | systemic lupus erythematosus
|
C0024141
Lupus Erythematosus, Systemic
|
scispacy | 1 | |
| 질환 | sarcoidosis
|
C0036202
Sarcoidosis
|
scispacy | 1 | |
| 질환 | Raynaud's phenomenon
|
C0034735
Raynaud Phenomenon
|
scispacy | 1 | |
| 질환 | DVT
|
C0149871
Deep Vein Thrombosis
|
scispacy | 1 | |
| 질환 | thrombosis
|
C0040053
Thrombosis
|
scispacy | 1 | |
| 질환 | abscess
|
C0000833
Abscess
|
scispacy | 1 | |
| 질환 | disease
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | collagen vascular
|
scispacy | 1 | ||
| 기타 | blood vessels
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | arterial
|
scispacy | 1 | ||
| 기타 | OR 5.7
|
scispacy | 1 |
MeSH Terms
Humans; Adolescent; Adult; Middle Aged; Aged; Free Tissue Flaps; Treatment Outcome; Plastic Surgery Procedures; Retrospective Studies; Postoperative Complications; Thrombosis; Connective Tissue Diseases; Collagen; Arthritis, Rheumatoid; Survival Analysis
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy.